Search Results - "Minsaas, L."

Olaparib monotherapy as primary treatment in unselected triple negative breast cancer by Eikesdal, H.P., Yndestad, S., Elzawahry, A., Llop-Guevara, A., Gilje, B., Blix, E.S., Espelid, H., Lundgren, S., Geisler, J., Vagstad, G., Venizelos, A., Minsaas, L., Leirvaag, B., Gudlaugsson, E.G., Vintermyr, O.K., Aase, H.S., Aas, T., Balmaña, J., Serra, V., Janssen, E.A.M., Knappskog, S., Lønning, P.E.

“…The antitumor efficacy of PARP inhibitors (PARPi) for breast cancer patients harboring germline BRCA1/2 (gBRCA1/2) mutations is well established. While PARPi…”
Get full text

White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk by Lønning, Per E, Berge, Elisabet O, Bjørnslett, Merete, Minsaas, Laura, Chrisanthar, Ranjan, Høberg-Vetti, Hildegunn, Dulary, Cécile, Busato, Florence, Bjørneklett, Silje, Eriksen, Christine, Kopperud, Reidun, Axcrona, Ulrika, Davidson, Ben, Bjørge, Line, Evans, Gareth, Howell, Anthony, Salvesen, Helga B, Janszky, Imre, Hveem, Kristian, Romundstad, Pål R, Vatten, Lars J, Tost, Jörg, Dørum, Anne, Knappskog, Stian

“…The role of normal tissue gene promoter methylation in cancer risk is poorly understood. To assess associations between normal tissue BRCA1 methylation and…”
Get full text